Soleno Therapeutics Inc (SLNO)
50.24 +0.10 (+0.20%) 09:52 ET [NASDAQ]
49.91 x 11 50.37 x 1
Realtime by (Cboe BZX)
49.91 x 11 50.37 x 1
Realtime 50.50 +0.36 (+0.72%) 09:30 ET
for Tue, Mar 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | SLNO | NAMS | CNTA | ||
| Company | Soleno Therapeutics Inc | Newamsterdam Pharma Company N.V. | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.74 | 24.40 | 16.53 | ||
| High | 50.81 | 24.40 | 16.62 | ||
| Low | 50.14 | 23.37 | 16.01 | ||
| Last | 50.24 | 24.05 | 16.23 | ||
| Change | +0.10 | +0.05 | -0.40 | ||
| % Change | +0.20% | +0.21% | -2.41% | ||
| Volume | 9,849 | 11,369 | 24,048 | ||
| 20-Day Average Volume | 643,389 | 1,272,052 | 979,393 | ||
| Previous Close | 50.14 | 24.00 | 16.63 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.21 | 22.83 | 16.34 | ||
| 20-Day Raw Stochastic | 98.80% | 88.44% | 53.28% | ||
| 20-Day Relative Strength | 57.44% | 57.76% | 49.40% | ||
| Weighted Alpha | +17.35 | -14.23 | +45.42 | ||
| Today's Opinion | 8% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | Hold | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 56% Sell | 24% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.07% since 03/18/25 | +0.38% since 03/18/25 | -0.64% since 03/18/25 | ||
| Low | 47.23 on 03/21/25 | 23.00 on 03/19/25 | 15.50 on 03/24/25 | ||
| High | 50.74 on 03/25/25 | 24.51 on 03/24/25 | 17.11 on 03/20/25 | ||
| 1-Month | |||||
| %Chg | +12.90% since 02/25/25 | +32.89% since 02/25/25 | +4.16% since 02/25/25 | ||
| Low | 43.00 on 03/11/25 | 18.03 on 02/26/25 | 14.62 on 02/28/25 | ||
| High | 50.74 on 03/25/25 | 24.51 on 03/24/25 | 17.97 on 03/13/25 | ||
| 3-Month | |||||
| %Chg | +13.13% since 12/24/24 | -8.44% since 12/24/24 | -2.93% since 12/24/24 | ||
| Low | 41.50 on 01/15/25 | 17.18 on 02/25/25 | 14.44 on 01/14/25 | ||
| High | 52.46 on 02/14/25 | 26.80 on 01/02/25 | 19.09 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | +3.83% since 09/25/24 | +55.91% since 09/25/24 | +6.94% since 09/25/24 | ||
| Low | 41.50 on 01/15/25 | 15.38 on 09/26/24 | 14.44 on 01/14/25 | ||
| High | 60.92 on 11/25/24 | 27.29 on 12/11/24 | 19.09 on 02/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,299,270 | 2,635,632 | 2,192,582 | ||
| Shares Outstanding, K | 45,857 | 109,818 | 131,845 | ||
| Annual Sales | 0 | 45,560,000 | 6,850,000 | ||
| Annual Net Income | -175,850,000 | -241,600,000 | -151,090,000 | ||
| Last Quarter Sales | 0 | 12,770,000 | 0 | ||
| Last Quarter Net Income | -55,980,000 | -92,180,000 | -42,570,000 | ||
| 60-Month Beta | -1.70 | -0.04 | 1.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.27 on 02/27/25 | -0.95 on 02/26/25 | -0.37 on 11/12/24 | ||
| Latest Earnings Date | 05/08/25 | 05/14/25 | 05/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||